Valion Bio, Inc. VBIO
0.49 USD -0.03 (-5.74%)
Nov 5, 2026, 3:10 PM EST
0.4732 Day range 0.52
0.4732 52-week range 67.50
- YTD
- -98.66%
- 1 year
- -99.21%
- Market cap
- 1.03M
- EPS (ttm)
- -177.91
- YTD return
- -98.66%
- 1-year return
- -99.21%
- Volume
- 105.34K
- Avg volume
- 1.98M
- Open
- 0.52
- Previous close
- 0.5171
- Day's range
- 0.4732 – 0.52
- 52-week range
- 0.4732 – 67.50
5D -0.1100 (-18.33%)
Financials — quick view
VBIO Revenue — quarterly 0
VBIO Net income — quarterly -7.10M
VBIO EPS — quarterly -54.00
News
12 Health Care Stocks Moving In Friday's After-Market Session 
Valion Bio Announces That The Armed Forces Radiobiology Research Institute Will Evaluate The Therapeutic Efficacy Of Entolimod 
Valion Bio Announces Final Data From Entolimod Study For Hematopoietic And Gastrointestinal Forms Of Acute Radiation Syndrome; AFRRI Study Found No Evidence Of Treatment-Related Toxicity After One Dose Of Entolimod, Supporting Advancement Toward A Fully Funded Therapeutic Study 
Why Celestica Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket 
12 Health Care Stocks Moving In Monday's Pre-Market Session 
Valion Bio Confirms Receipt Of Proposed Acquisition Offers For Its Velocity Bioworks; Terms Undisclosed 
12 Health Care Stocks Moving In Thursday's After-Market Session 
Valion Bio's New Leadership Unveils 30-Day Agenda to Accelerate Clinical Pipeline and Unlock Shareholder Value 
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Valion Bio's Velocity Biowork Subsidiary Completes Initial Feasibility Evaluation Of LarmorBio's BioScan-NMR Platform
Your note
Sign in to keep a note on VBIO — it syncs with the Stock Master app.